InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: hutschi post# 240300

Monday, 10/26/2015 2:28:17 PM

Monday, October 26, 2015 2:28:17 PM

Post# of 346183
Do we have the comparative analysis figures for OS?

A topline analysis revealed that treatment with KEYTRUDA was associated with longer overall survival (OS) compared with docetaxel treatment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News